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The strategies for managing the health crisis triggered by 
the COVID-19 pandemic differ from country to country, 
but “there has never been such a rapid global collective effort 
to fight one disease” (1). The scientific community respond-
ed to the crisis by extensive mobilization of all research re-
sources with an aim to shed light on the virus characteris-
tics, mechanisms of its transmission, clinical aspects of the 
disease, and prevention and management strategies. The 
number of articles arising from clinical studies and obser-
vations has so far multiplied at an unprecedented rate. The 
largest number has been published in scientific journals, 
which have responded to this epidemiological and infor-
mation crisis in accordance with their role in the transmis-
sion of new scientific information – quickly, openly, effec-
tively, and responsibly (2).
In the past three months, the medical information system 
has been hit by a storm marked by a large daily increase 
in published articles, accelerated review processes, curat-
ed hubs for easy and effective access, greater attention to 
preprint platforms, and free access to all pandemic-relat-
ed articles.
A good example of a tool for keeping up with the pub-
lished SARS-CoV-2/COVID-19 articles is LitCovid – a curat-
ed literature hub for tracking up-to-date scientific informa-
tion about the 2019 novel coronavirus (LitCovid: https://
www.ncbi.nlm.nih.gov/research/coronavirus/). By April 
21st, it provided central access to 5761 relevant articles in 
PubMed, and the number is growing daily. The articles are 
further categorized by research topics and geographic lo-
cations for improved access (3). The growth curve of the 
number of new publications being included in the data-
base begins to resemble the contagion curve (Figure 1)
In the week of April 13-19, the database included a whop-
ping 1608 articles. Additional five hundred non peer-re-
viewed articles were posted on several of the most im-
portant preprint services. Most of the articles included in 
LitCovid were published by traditionally leading medical 
journals – The BMJ, The Lancet, Nature, the New England Jour-
nal of Medicine, JAMA, etc. These articles are mostly from 
the fields of general information and prevention, control, 
and management strategies, while in the fields of trans-
mission mechanism, diagnosis and treatment, the leading 
journal is Journal of Medical Virology. One of the journals 
with a large number of published articles is Zhonghua Liu 
Xing Bing Xue Za Zhi (Chinese Journal of Epidemiology).
Why do most influential journals publish the most of these 
articles? Is it because the authors, knowing that the issue is 
new, aspire to the best journals, reckoning that their works 
will be more noticed and they will add another “badge” 
to their CVs? Or do these reputable journals, by advanc-
ing knowledge on COVID-19, want to reinforce their role 
in the information aspect of this crisis? Or do reputable 
FiGure 1. The number of publications added to LitCovid per 
week.
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journals simply have the infrastructure (editors, review-
ers, funds) that can handle this pressure? Probably the an-
swer lies in the combination of these factors. However, the 
question is whether these journals lowered their criteria 
and whether the “mitigated” review process was a reason 
for accepting articles that would not, under “normal” cir-
cumstances, be accepted in the journals known for their 
high manuscript rejection rate. And what will be decisive 
in stopping this publishing inflation? Scientific scrutiny, 
market, or public interest?
The scientific community has started to exercise cau-
tion regarding the relationship between the benefits of 
the rapid transfer of new insights and the potential harm 
from the diminished quality of published articles due to 
the expedited review process and methodological and 
reporting shortcomings (4). The time between the initial 
submission and final acceptance is much lower than usu-
ally reported (5), while the research is often superficial, 
poorly designed, and underpowered (6). According to 
the Retraction Watch Database, some of these have al-
ready been retracted.
Before the outbreak of this epidemic, preprint servers with 
medical articles were not as important as in some other 
scientific disciplines, such as physics. The reason can be 
found in the reluctance of the clinical medical community 
to publish unverified medical information that can bring 
harm if doctors change clinical guidelines or patients try 
treatments on their own based on findings that have not 
been vetted by peer reviewers (7). In recent months, this 
has changed, and the medRxiv, bioRxiv, SSRN’s eLibrary, 
and Research Square platforms publish several hundred ar-
ticles daily, accelerating the communication of new results. 
medRxiv points out that preprints are preliminary reports 
that have not been peer reviewed and that all manuscripts 
undergo a basic screening process for offensive or non-sci-
entific content and for material that may pose a health risk, 
while simultaneously being checked for plagiarism. Nev-
ertheless, these articles should not be relied on to guide 
clinical practice or health-related behaviors and should not 
be reported in news media as established information. The 
latter happens, however, on a daily basis, and the scientif-
ic community warns about the potential consequences of 
publishing such information (6).
Even prestigious journals (eg, Lancet, the BMJ) now allow 
the sharing of important findings before peer review, and 
the use of preprint platforms does not jeopardize the 
future of peer-reviewed publication (8).
Although Ingelfinger noted in 1977 that “medicine has be-
come the stuff of headlines” (9), the results of scientific re-
search have never had such a media impact as today. On 
the one hand, this has positive effects. The media spotlight 
has turned to medical professionals, who are reporting on 
a daily basis on current epidemic developments. Epidemi-
ologists and infectious diseases specialists have become 
the new type of influencers, and the public partly bases 
their views on the information thus obtained. On the oth-
er hand, social networks and other media may also misin-
form, so caution is being exercised in the scientific com-
munity toward sources and interpretations of scientific 
facts in the media space.
Publication in open access serves the public good, and in-
formation on SARS-CoV-2 and COVID-19 is available free of 
charge to anyone in the epidemic research and control sys-
tem. Now, we can finally experience what it would be like 
to live in a world based on free-for-all medical information. 
It began with the initiative of Free Read, which in early Feb-
ruary launched the petition Unlock Coronavirus Research 
for the world’s scientists, to which reputable medical pub-
lishers (Elsevier, Taylor & Francis, Wiley, Springer and oth-
ers) soon responded. The petition stated that “unlocking” 
articles published in commercial journals and widening 
access to all research data are a moral imperative of the 
coronavirus crisis. Publishers soon created separate portals 
or dedicated sites with open access to the consolidated 
articles of their journal portfolio. Academic social networks 
responded similarly, creating COVID-19 user communities.
Rapid collection and sharing of available research data are 
enhanced by freely available datasets. One of the largest 
is the COVID-19 Open Research Dataset (CORD-19). The 
European Commission with several partners (University 
of Zagreb Computing Center being one of them) has just 
launched a European COVID-19 Data Platform as well.
According to many indicators, Croatia has managed this 
public health crisis successfully. The results of various ma-
jor or minor studies of epidemiological and clinical nature 
will certainly emerge in the near future. For now, PubMed 
shows 18 articles on some of the aspects of COVID-19 
published by Croatian authors alone or in collaboration 
with foreign authors (Supplementary Table 1). These are 
mostly position statements and opinion articles. More 
than half (10/18) were published in high-impact journals, 
consistent with our findings that articles related to the 
COVID-19 pandemic are largely published by the most in-
fluential medical journals.
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Croatian Medical Journal (CMJ) responded immediately to 
the pandemic by an editorial in the February issue requir-
ing urgent epidemiologic surveillance (10). Analyses on 
the COVID-19 crisis management are yet to be published, 
and any manuscript on the subject is welcome. The open 
access policy advocated and implemented by the CMJ 
for more than 15 years (11) will ensure that the published 
works have permanent, unrestricted, and free access. In ad-
dition, since our goal is not to compete with the largest 
and most influential journals, our publications will contin-
ue to be carefully peer reviewed. By this we do not claim 
that our work is of better or lesser quality, but only specific 
to the level we aspire to and the audience we address.
The large amount of new scientific information, or “sci-
infodemic,” mostly published in medical journals brought 
about by this global health crisis, and its impact on the pro-
fessional community and the general public, have made 
scientific research and its applications one of the main fo-
cuses of public policies. They have also shown, in an un-
precedented way, all the benefits of open access in the 
transfer and reception of new scientific knowledge. At this 
point, it should be emphasized that well designed system-
atic reviews are particularly important to the professional 
medical audience in coping with this explosion of informa-
tion. However, some authors warn that the methodologi-
cal quality of most of the systematic reviews on previous 
coronavirus outbreaks is still unsatisfactory, and that those 
on COVID-19 have higher risk of poor quality, possibly be-
cause of the rapid actions performed to conduct them 
(12). The importance of information literacy and critical re-
ception of published information in this crisis should also 
be emphasized.
Can the positive changes observed in the way medi-
cal journals cope with the information crisis caused by 
COVID-19 be sustained once we emerge from the crisis? 
Can the review process be expedited? Can publishers al-
low more articles on preprint servers and more commu-
nity-based peer reviews? Can journal editorial boards con-
tinue this new practice by publishing OA (free of charge) 
articles that provide key information for public health or 
on the most common diseases? We will not have to wait 
long for the answers.
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